<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Health Newspapers — Policy</title>
    <link>https://www.healthnewspapers.com/policy</link>
    <description>The FDA, the CDC, the courts, coverage, and what things cost.</description>
    <language>en-us</language>
    <atom:link href="https://www.healthnewspapers.com/policy/rss.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>HHS declares grounds for emergency use of pain drugs for military casualties</title>
      <link>https://www.healthnewspapers.com/policy/military-emergency-eua-acute-pain-drugs</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/military-emergency-eua-acute-pain-drugs</guid>
      <description>A section 564 declaration, prompted by a July determination from the Secretary of War, opens the door to authorising unapproved drugs for acute pain in combat and CBRN casualties.</description>
      <pubDate>Fri, 04 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>A JAMA perspective describes an outside effort to shore up US vaccine advice</title>
      <link>https://www.healthnewspapers.com/policy/vaccine-integrity-project-respiratory-vaccines</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/vaccine-integrity-project-respiratory-vaccines</guid>
      <description>The Vaccine Integrity Project, formed in 2025 amid disruptions to the CDC&apos;s immunisation advisory committee, sets out its process for reviewing 2026–2027 respiratory-season vaccines.</description>
      <pubDate>Thu, 03 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>NIH moves to license a government-owned mifepristone dosing method to a French firm</title>
      <link>https://www.healthnewspapers.com/policy/nih-mifepristone-license-hypercortisolism-insulin-resistance</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/nih-mifepristone-license-hypercortisolism-insulin-resistance</guid>
      <description>The patented method uses mifepristone for hypercortisolism-related insulin resistance, with dosing capped to avoid over-activating the stress-hormone axis. The public can object before the deal closes.</description>
      <pubDate>Thu, 03 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>COVID and RSV shots still cut severe illness, two 2026-2027 season reviews find</title>
      <link>https://www.healthnewspapers.com/policy/respiratory-season-vaccine-effectiveness-2026-2027</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/respiratory-season-vaccine-effectiveness-2026-2027</guid>
      <description>JAMA published paired systematic reviews for the coming respiratory season. Both found vaccines reduced hospitalisation across age groups, with no new safety signals, though protection wanes over time.</description>
      <pubDate>Wed, 02 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA rewrites its guidance on studying drug doses in liver-impaired patients</title>
      <link>https://www.healthnewspapers.com/policy/fda-hepatic-impairment-pk-guidance-update</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-hepatic-impairment-pk-guidance-update</guid>
      <description>A draft replacing a 2003 document would extend hepatic-impairment dosing studies to biologic drugs and to drug effects, not just blood levels. It is open for comment before the agency finalises it.</description>
      <pubDate>Wed, 02 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>NIAID proposes to abolish its Division of Clinical Research and several offices</title>
      <link>https://www.healthnewspapers.com/policy/niaid-division-clinical-research-abolition</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/niaid-division-clinical-research-abolition</guid>
      <description>A Federal Register notice opens a five-day comment window in September. The stated goal is to realign clinical operations across the institute and align with Presidential priorities.</description>
      <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>A drug&apos;s &apos;price&apos; is two different numbers, and the gap can be enormous</title>
      <link>https://www.healthnewspapers.com/policy/list-price-versus-net-price-drug-gap</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/list-price-versus-net-price-drug-gap</guid>
      <description>The list price is the sticker; the net price is what the maker keeps after rebates. For one insulin, list rose 27% over five years as the net price fell 10%. Who you are decides which you pay.</description>
      <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>EMA reopens its animal-testing alternatives channel after a decade of near-zero uptake</title>
      <link>https://www.healthnewspapers.com/policy/ema-nams-voluntary-data-submission-pilot</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/ema-nams-voluntary-data-submission-pilot</guid>
      <description>The 2012 safe harbour for 3Rs data was barely used. The replacement is a voluntary pilot that takes submissions independently of a marketing application, running until the third quarter of 2027.</description>
      <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Saudi Arabia reports serious road crashes down 46% over a decade</title>
      <link>https://www.healthnewspapers.com/policy/saudi-road-traffic-injury-decline</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/saudi-road-traffic-injury-decline</guid>
      <description>A review by the country&apos;s Public Health Authority credits enforcement and awareness campaigns for falls in crashes, deaths and injuries from 2013 to 2023 — while naming what still holds the Vision 2030 target back.</description>
      <pubDate>Mon, 31 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Europe&apos;s cardiologists issued three new guidelines at once, two of them firsts</title>
      <link>https://www.healthnewspapers.com/policy/esc-2026-guidelines-heart-failure-kidney-rehabilitation</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/esc-2026-guidelines-heart-failure-kidney-rehabilitation</guid>
      <description>The ESC released updated heart failure guidance plus first-ever guidelines on cardiac rehabilitation and on cardiovascular disease with chronic kidney disease. All three sit behind a paywall.</description>
      <pubDate>Mon, 31 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>One in five working Medicaid enrollees could fail work reporting by working the wrong week</title>
      <link>https://www.healthnewspapers.com/policy/medicaid-work-reporting-variable-hours-risk</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/medicaid-work-reporting-variable-hours-risk</guid>
      <description>A study of Current Population Survey data finds 19.8% of likely expansion enrollees sit near the 20-hour threshold or report variable hours. Women are at higher risk than men.</description>
      <pubDate>Fri, 28 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Medical debt is the largest US debt in collections. Erasing it changed little.</title>
      <link>https://www.healthnewspapers.com/policy/medical-debt-and-health-what-evidence-shows</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/medical-debt-and-health-what-evidence-shows</guid>
      <description>Americans owed about $140 billion in medical bills in collections. But two randomized experiments that relieved debt found no average effect on credit, financial distress or mental health.</description>
      <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Medicaid expansion changed who paid for 12 million births, not severe maternal morbidity</title>
      <link>https://www.healthnewspapers.com/policy/medicaid-expansion-severe-maternal-morbidity</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/medicaid-expansion-severe-maternal-morbidity</guid>
      <description>Across 26 states, expansion raised the Medicaid-paid share of deliveries by 5.2% and changed the severe maternal morbidity rate by 0.02% — an interval that includes zero in both directions.</description>
      <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA moves a diabetes trial&apos;s retinopathy data into Zepbound&apos;s obesity label</title>
      <link>https://www.healthnewspapers.com/policy/zepbound-label-update-surpass-cvot-retinopathy</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/zepbound-label-update-surpass-cvot-retinopathy</guid>
      <description>A supplement approved on 26 August adds SURPASS-CVOT to the prescribing information and rewrites the eye warning so it is addressed to patients with a history of retinopathy rather than to patients with diabetes.</description>
      <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Three companies you&apos;ve never chosen decide much of what your drugs cost</title>
      <link>https://www.healthnewspapers.com/policy/what-is-a-pbm-why-it-affects-what-you-pay</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/what-is-a-pbm-why-it-affects-what-you-pay</guid>
      <description>Pharmacy benefit managers sit between you, your insurer and the pharmacy. The three largest process nearly 80% of US prescriptions, and a federal regulator says the structure can raise costs.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>A survey of 166 HIV organizations found 1,700 clinics closed after US funding cuts</title>
      <link>https://www.healthnewspapers.com/policy/pepfar-hiv-funding-disruption-amfar-survey</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/pepfar-hiv-funding-disruption-amfar-survey</guid>
      <description>Seventy-seven thousand fewer children got PEPFAR-supported HIV treatment in 2025 than the year before. UNAIDS warns permanent cuts could mean millions of additional infections and deaths by 2029.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Congress gave NIH $47.2 billion, rejecting the White House&apos;s proposed 40% cut</title>
      <link>https://www.healthnewspapers.com/policy/nih-fy2026-funding-congress-rejects-cuts</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/nih-fy2026-funding-congress-rejects-cuts</guid>
      <description>The administration wanted to consolidate NIH&apos;s 27 institutes into eight and cut roughly $18 billion from its budget. The signed law does neither.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>The NHS recorded its three busiest months ever, with wards hitting nearly 42°C</title>
      <link>https://www.healthnewspapers.com/policy/nhs-heatwave-record-ae-demand-2026</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/nhs-heatwave-record-ae-demand-2026</guid>
      <description>England&apos;s A&amp;E departments handled 2.5 million attendances in July alone. Nursing staff say wards without air conditioning are becoming an occupational-safety problem, not just a patient-comfort one.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Medicare telehealth got a two-year extension. The cliff it keeps dodging remains.</title>
      <link>https://www.healthnewspapers.com/policy/medicare-telehealth-extended-through-2027</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/medicare-telehealth-extended-through-2027</guid>
      <description>The pandemic-era rules letting Medicare patients see a doctor from home, anywhere in the country, are now locked in through the end of 2027 — the longest extension since they were created.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>CMS wants Medicare drug-price negotiation locked into permanent rules</title>
      <link>https://www.healthnewspapers.com/policy/medicare-drug-price-negotiation-permanent-framework</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/medicare-drug-price-negotiation-permanent-framework</guid>
      <description>The public comment window just closed on a proposal that would govern how up to 20 high-cost drugs a year get their Medicare prices negotiated, starting with prices that take effect in 2029.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>A judge let Medicaid work requirements proceed, with the deeper fight unresolved</title>
      <link>https://www.healthnewspapers.com/policy/medicaid-work-requirements-judge-denies-injunction</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/medicaid-work-requirements-judge-denies-injunction</guid>
      <description>Twenty-five states wanted the rule paused while they sued. The judge said the 90% federal reimbursement for setup costs undercut their case for emergency relief — not that their underlying legal argument was wrong.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>A judge found Idaho&apos;s abortion ban unconstitutional for lacking a health exception</title>
      <link>https://www.healthnewspapers.com/policy/idaho-abortion-health-exception-ruling</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/idaho-abortion-health-exception-ruling</guid>
      <description>The court didn&apos;t strike down Idaho&apos;s ban. It said the state can&apos;t prosecute doctors for abortions performed to protect a patient&apos;s health, not just her life. Idaho is appealing.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Generic drugs get a two-year tariff grace period, then a 100% tariff, then 200%</title>
      <link>https://www.healthnewspapers.com/policy/generic-drug-tariffs-phased-plan</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/generic-drug-tariffs-phased-plan</guid>
      <description>The administration wants pharmaceutical manufacturing back on US soil. The runway it&apos;s offering is shorter than the time it typically takes to build and validate a new drug plant.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>The US unfroze $600 million for global vaccines after a year-long standoff</title>
      <link>https://www.healthnewspapers.com/policy/gavi-600-million-funding-released-mercury-dispute</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/gavi-600-million-funding-released-mercury-dispute</guid>
      <description>HHS Secretary Kennedy held the money over Gavi&apos;s use of a mercury-based preservative most safety reviews call harmless in trace amounts. Gavi says it was already phasing the ingredient out.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>A new class of myeloma drug was approved on a more sensitive test of remission</title>
      <link>https://www.healthnewspapers.com/policy/fda-zenbexus-iberdomide-multiple-myeloma-celmod</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-zenbexus-iberdomide-multiple-myeloma-celmod</guid>
      <description>Zenbexus didn&apos;t have to outlive patients in a control arm to win approval — it had to clear their bone marrow of detectable disease faster. That shortcut is becoming the norm, not the exception.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA approves the first drug aimed at the cause of narcolepsy type 1, not just its symptoms</title>
      <link>https://www.healthnewspapers.com/policy/fda-orzeyful-oveporexton-narcolepsy-type-1-approval</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-orzeyful-oveporexton-narcolepsy-type-1-approval</guid>
      <description>Orzeyful replaces signaling from the brain chemical narcolepsy patients lack, rather than stimulating wakefulness around the gap. Two-thirds of patients on the higher dose had trouble sleeping.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>The FDA wants food companies to stop self-certifying their own ingredients as safe</title>
      <link>https://www.healthnewspapers.com/policy/fda-gras-reform-ultra-processed-food-definition</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-gras-reform-ultra-processed-food-definition</guid>
      <description>For decades a manufacturer could add a new ingredient and privately decide it was generally recognized as safe without telling the FDA. A proposed rule would end that loophole.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA clears first gene therapy for a rare disorder managed with round-the-clock cornstarch</title>
      <link>https://www.healthnewspapers.com/policy/fda-genglycos-gene-therapy-gsdia-approval</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-genglycos-gene-therapy-gsdia-approval</guid>
      <description>GENGLYCOS treats the cause of glycogen storage disease type Ia, not just the symptoms cornstarch regimens manage — but it carries a long list of serious risks and an accelerated-approval asterisk.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA authorizes a robot that draws blood without a phlebotomist&apos;s hands on the needle</title>
      <link>https://www.healthnewspapers.com/policy/fda-aletta-robotic-blood-draw-device</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-aletta-robotic-blood-draw-device</guid>
      <description>The Aletta still needs a trained supervisor in the room, but it locates the vein, inserts the needle and fills the tubes on its own — and one person can now watch three of them at once.</description>
      <pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>The same operation at one hospital can cost thousands more on another plan</title>
      <link>https://www.healthnewspapers.com/policy/hospital-prices-vary-transparency-rules</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/hospital-prices-vary-transparency-rules</guid>
      <description>Since 2021, hospitals must post the rates they negotiate with each insurer. The data confirms the same procedure at the same hospital varies widely by which insurer is paying.</description>
      <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Prior authorization delays care. A federal audit shows some denials are wrong.</title>
      <link>https://www.healthnewspapers.com/policy/prior-authorization-what-evidence-shows</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/prior-authorization-what-evidence-shows</guid>
      <description>Physician surveys report delays and abandoned treatment; those are self-reported. A harder number: a federal audit found 13% of Medicare Advantage denials met Medicare&apos;s own coverage rules.</description>
      <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Screening guidelines disagree because the same trials support more than one answer</title>
      <link>https://www.healthnewspapers.com/policy/cancer-screening-ages-why-guidelines-disagree</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/cancer-screening-ages-why-guidelines-disagree</guid>
      <description>US guidance recommends mammography from 40. A Canadian review of the same randomised evidence put the benefit at 0.27 fewer breast cancer deaths per 1,000 women aged 40-49 over ten years.</description>
      <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>The $35 insulin cap is federal law only for Medicare. Gaps remain.</title>
      <link>https://www.healthnewspapers.com/policy/why-insulin-still-expensive-after-caps</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/why-insulin-still-expensive-after-caps</guid>
      <description>Medicare&apos;s cap is statutory; the commercial version is a voluntary manufacturer promise with conditions. Before the caps, 1.3 million adults rationed insulin because of cost.</description>
      <pubDate>Thu, 13 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>A federal court froze the 2026 childhood vaccine schedule. Who writes it is the fight.</title>
      <link>https://www.healthnewspapers.com/policy/acip-immunization-schedule-court-stay</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/acip-immunization-schedule-court-stay</guid>
      <description>The advisory committee that shaped U.S. immunization policy for decades was replaced, then bypassed. In March a judge stayed the result.</description>
      <pubDate>Wed, 12 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Medicare&apos;s first negotiated drug prices cut 10 drugs 38% to 79%, from 2026</title>
      <link>https://www.healthnewspapers.com/policy/medicare-negotiation-what-changed-which-drugs</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/medicare-negotiation-what-changed-which-drugs</guid>
      <description>The prices apply only to 10 drugs, only in Medicare, and only from January 2026. Here is exactly which drugs, by how much, and who actually sees the difference.</description>
      <pubDate>Tue, 11 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Turkish doctors named violence against health workers as the top reason to leave</title>
      <link>https://www.healthnewspapers.com/policy/turkey-physician-brain-drain</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/turkey-physician-brain-drain</guid>
      <description>A study of 1,331 physicians put violence ahead of pay. Of 32 doctors who had already emigrated, two were considering coming back — and none of the women were.</description>
      <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>US brand-name drug prices average more than four times those abroad</title>
      <link>https://www.healthnewspapers.com/policy/why-us-drug-prices-highest-how-set</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/why-us-drug-prices-highest-how-set</guid>
      <description>Across all drugs, US prices are 2.78 times those in 33 other wealthy countries. The gap is not that Americans use more medicine — it is that no one sets the launch price.</description>
      <pubDate>Tue, 04 Aug 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>The mechanism FDA will use to restrict GLP-1 compounding is now on the record</title>
      <link>https://www.healthnewspapers.com/policy/fda-glp1-503b-bulks-list-comment-period-closes</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-glp1-503b-bulks-list-comment-period-closes</guid>
      <description>In February, FDA said it intended to act against compounded GLP-1 supply without saying how. The answer arrived in May: exclude semaglutide, tirzepatide and liraglutide from the list.</description>
      <pubDate>Fri, 31 Jul 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>China approved more cancer drugs than the FDA over six years, and reviewed them slower</title>
      <link>https://www.healthnewspapers.com/policy/nmpa-fda-oncology-approvals-comparison</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/nmpa-fda-oncology-approvals-comparison</guid>
      <description>A comparison of 2020–2025 approvals finds 94 novel oncology drugs from the NMPA against 87 from the FDA, with China&apos;s volume overtaking from 2023. The speed and first-in-class figures run the other way.</description>
      <pubDate>Tue, 28 Jul 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA approves a new ADHD drug. It still needs the DEA&apos;s sign-off before anyone can buy it</title>
      <link>https://www.healthnewspapers.com/policy/fda-simtriyo-centanafadine-adhd-approval</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-simtriyo-centanafadine-adhd-approval</guid>
      <description>Simtriyo works on a different neurotransmitter pathway than existing stimulants. But its own manufacturer classifies it as a CNS stimulant, so a scheduling review stands before pharmacy shelves.</description>
      <pubDate>Sat, 25 Jul 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Australia subsidised five new heart drugs in three years. New Zealand funded one change</title>
      <link>https://www.healthnewspapers.com/policy/pbs-pharmac-cardiovascular-access-divergence</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/pbs-pharmac-cardiovascular-access-divergence</guid>
      <description>A first consolidated audit of PBS and PHARMAC cardiovascular listings from 2023 to 2025 finds a widening access gap between two neighbouring countries with similar disease burdens.</description>
      <pubDate>Tue, 21 Jul 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>EU regulators moved to revoke a rare-disease drug over its pivotal trial data</title>
      <link>https://www.healthnewspapers.com/policy/ema-chmp-june-2026-avacopan-revocation</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/ema-chmp-june-2026-avacopan-revocation</guid>
      <description>The CHMP&apos;s June meeting recommended pulling avacopan from the EU market on data-integrity grounds, refused three cell and biological therapies, and reversed itself on a Rett syndrome drug it had earlier rejected.</description>
      <pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA approves the first pill in a cholesterol drug class that has only ever been injectable</title>
      <link>https://www.healthnewspapers.com/policy/fda-lipfendra-oral-pcsk9-approval</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/fda-lipfendra-oral-pcsk9-approval</guid>
      <description>Lipfendra cut LDL cholesterol by more than half in two trials. Its significance is less the number than the format: a once-daily tablet where every prior PCSK9 inhibitor required a needle.</description>
      <pubDate>Sat, 18 Jul 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Four months after a court froze the vaccine schedule, the US still has no functioning ACIP</title>
      <link>https://www.healthnewspapers.com/policy/acip-no-quorum-four-months-after-stay</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/acip-no-quorum-four-months-after-stay</guid>
      <description>The appeal is moving on an expedited track, with a status report due this month. But CIDRAP&apos;s vaccine-policy trackers make a pointed argument: a working committee could exist right now, if HHS chose to seat one.</description>
      <pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>ACA marketplace enrollment fell 13% this year. HHS says most of the drop was overdue</title>
      <link>https://www.healthnewspapers.com/policy/aca-marketplace-enrollment-2026-fraud-report</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/aca-marketplace-enrollment-2026-fraud-report</guid>
      <description>A new administration analysis estimates 2.9 million people were removed from ACA exchange plans as improperly or fraudulently enrolled — and that 2.6 million more remain.</description>
      <pubDate>Mon, 29 Jun 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>CDC posts a new ACIP charter that drops the vaccine-expertise requirement</title>
      <link>https://www.healthnewspapers.com/policy/acip-charter-revised-expertise-requirements</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/acip-charter-revised-expertise-requirements</guid>
      <description>The committee&apos;s founding document now asks for a &apos;balanced range&apos; of expertise rather than vaccine-specific knowledge, and adds review of non-vaccine alternatives to its mandate.</description>
      <pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Japan&apos;s long-term care insurance passed its equity test — with one exception</title>
      <link>https://www.healthnewspapers.com/policy/japan-long-term-care-insurance-equity</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/japan-long-term-care-insurance-equity</guid>
      <description>Twenty-two years of national data show income-related inequities in care use narrowing, and copayment increases for higher earners not reversing that. Services carrying extra user charges are the outlier.</description>
      <pubDate>Tue, 09 Jun 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Brazil&apos;s regulator approved 18 new cancer drugs in five years. The FDA approved 73.</title>
      <link>https://www.healthnewspapers.com/policy/anvisa-oncology-approval-lag-sus-incorporation</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/anvisa-oncology-approval-lag-sus-incorporation</guid>
      <description>A comparison of FDA, EMA and ANVISA decisions from 2020 to 2024 finds Brazilian approvals arriving about a year later. A second study clocks the wait for public-system financing in years, not months.</description>
      <pubDate>Thu, 04 Jun 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>FDA approves the first pill meant to stop COVID-19 before it starts</title>
      <link>https://www.healthnewspapers.com/policy/ensitrelvir-xocova-post-exposure-approval</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/ensitrelvir-xocova-post-exposure-approval</guid>
      <description>Xocova is taken after a known exposure, not after symptoms appear. In a 2,041-person trial it cut symptomatic infection by 67% through day 10.</description>
      <pubDate>Wed, 03 Jun 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
    <item>
      <title>Europe&apos;s new heart plan rests on data showing a twofold mortality gap inside the continent</title>
      <link>https://www.healthnewspapers.com/policy/esc-atlas-2025-safe-hearts-plan-inequality</link>
      <guid isPermaLink="true">https://www.healthnewspapers.com/policy/esc-atlas-2025-safe-hearts-plan-inequality</guid>
      <description>The ESC Atlas reports 68 million disability-adjusted life years and more than three million cardiovascular deaths a year, with middle-income countries carrying roughly double the mortality of high-income ones.</description>
      <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
      <category>policy</category>
    </item>
  </channel>
</rss>